MedTrace Logo

Pancreatic Fistula After Minimally Invasive Enucleation

NCT06557408 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 173

Last updated 2024-11-07

No results posted yet for this study

Summary

Patients suffering from postoperative pancreatic fistula (POPF) after minimally invasive enucleation (MIEN) show a characteristic pattern of longer duration and milder symptoms, which is different from pancreatic fistula after standard pancreatectomy. This study aimed to analyze the factors influencing clinically-relevant POPF (CR-POPF) after MIEN, investigate and develop a personalized predictive model for accurate prediction of CR-POPF.

Conditions

  • Pancreatic Tumor, Benign
  • Pancreatic Neuroendocrine Tumor
  • Solid Pseudopapillary Tumor of the Pancreas

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Xianjun Yu, MD, PhD · Fudan University

  • Xiaowu Xu, MD · Fudan University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2022-11-30
Completion
2024-07-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06557408 on ClinicalTrials.gov